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Abstract: In recent years the proportion and complexity of software in medical devices has increased considerably. 
This has presented an opportunity for software development organisations to expand into the medical device 
domain. Due to the high level of risk associated with medical devices, strict regulations must be adhered to 
in order to market such products. One key aspect of these regulations is the necessity to have in place a 
Quality Management System to help ensure an organisations’ ability to consistently meet customer and 
regulatory requirements. This paper presents a roadmap which can be used to assist organisations, wishing 
to develop medical device software to implement a Quality Management System. 
1. INTRODUCTION 
Advancements in technology have allowed medical 
practitioners to provide a higher level of care to 
patients and offer a wider range of treatment options. 
However, when technology is used there is a risk to 
the patient if that device should fail. To offset these 
risks organisations must comply with the regulatory 
requirements of the country where the device is to be 
sold (Burton et al., 2006).  
Software is becoming a more pivotal component 
of medical devices due to its flexibility and its 
ability to allow complex changes to be made, 
without the need for hardware changes (Lee et al., 
2006), resulting in increased medical device 
software complexity (Rakitin, 2006). In addition 
software can now in its own right also be considered 
a medical device (Mc Hugh et al., 2011). Therefore 
software development organisations are subjected to 
the same regulatory requirements as other medical 
device organisations. 
Software organisations now have an opportunity 
to expand into the medical domain. These 
organisations however must develop more stringent 
processes in order to meet regulatory compliance. A 
significant difficulty for such organisations is that 
there is no prescribed method for performing 
regulatory compliant software development 
activities (McCaffery et al., 2010). Regulatory 
bodies instead provide guidance documents 
outlining what activities should be performed 
(McCaffery et al., 2010).  
To help address this shortfall this paper details a 
software development process roadmap which can 
be used to guide organisations through the 
implementation of a Quality Management System 
(QMS) which is compliant with the ISO 13485 (ISO, 
2003) standard. The roadmap presented here has 
been developed using the specific practices defined 
in the Medi SPICE process assessment model, which 
is designed to assess an organisations ability to 
develop medical device software. 
This paper is structured as follows. Section 2 
introduces the Medi SPICE (McCaffery et al., 2010) 
framework. Section 3 Introduces ISO 13485 and 
details a roadmap for implementing a QMS, while 
Section 4 outlines how the roadmap will be 
validated. Section 5 details some of the limitations 
of the roadmap and how these will be addressed in 
the future. Conclusions are provided in Section 6. 
2. MEDI SPICE 
As regulatory bodies only detail what activities must 
be performed, medical device organizations have 
been compliance centric in their approach to 
software development. As a result  there has been 
 very limited adoption of software process 
improvement within the medical device domain 
(Denger et al., 2007).   
Existing generic Software Process Improvement 
(SPI) models, such as the Capability Maturity Model 
Integration (CMMI®) (CMMI Product Team, 2006) 
and  ISO 15504-5:2012 (ISO/IEC 15504-5:2012, 
2012) (SPICE), do not provide sufficient coverage to 
achieve medical device regulatory compliance 
(McCaffery and Dorling, 2010).  To address this 
issue a medical device specific SPI framework, titled 
Medi SPICE, has been developed.  
The objective of undertaking a Medi SPICE 
assessment is to determine the state of a medical 
device organisation’s software processes and 
practices. This is in relation to the regulatory 
requirements of the industry and best practice with 
the goal of  identifying  areas for undertaking 
process improvement (McCaffery and Dorling, 
2010).  It can also be used as part of the  supplier 
selection process when an organisation wishes to 
outsource or offshore part or all of their medical 
device software development to a third party or 
remote division (Casey, 2010).  
Medi SPICE is based upon the latest version of 
ISO/IEC 15504-5:2012 and  ISO/IEC 12207:2008 
(ISO/IEC, 2008). It is being developed in line with 
the requirements of ISO/IEC 15504-2:2003 
(ISO/IEC, 2003) and contains a  Process Reference 
Model (PRM) and Process Assessment Model 
(PAM). It also incorporates the requirements of the 
relevant medical device regulations, standards, 
technical reports and guidance documents. 
The Medi SPICE PRM consists of 44 processes 
and 15 subprocesses which are fundamental to the 
development of regulatory compliant medical device 
software. Each process has a clearly defined purpose 
and outcomes that must be accomplished to achieve 
that purpose.  
Medi SPICE also contains a PAM which is 
related to the PRM and forms the basis for collecting 
evidence that may be used to provide a rating of 
process capability. This is achieved by the provision 
of a two-dimensional view of process capability. In 
one dimension, it describes a set of process specific 
practices that allow the achievement of the process 
outcomes and purpose defined in the PRM; this is 
termed the process dimension. In the second 
dimension, the PAM describes capabilities that 
relate to the process capability levels and process 
attributes, this is termed the capability dimension. 
3. QMS ROADMAP 
The ISO 13485 – Medical devices - Quality 
management systems – Requirements for regulatory 
purposes, is an international standard defining the 
requirements for the implementation of a QMS to be 
used for the development of medical devices. The 
standard not only covers software but also 
incorporates hardware and related activities such as 
production and servicing. 
The main focus of the QMS is to help insure that 
high quality processes are implemented and 
monitored. The standard places a strong emphasis on 
ensuring the organisation is committed to the quality 
of their products, through effective process 
management and a commitment to quality from all 
levels of the organisation from top management 
down. 
To assist organisations to implement a QMS, a 
roadmap has been developed. The roadmap is 
divided into three phases. The first phase is project 
planning and should occur at the start of a medical 
device software development project.  
The second phase is the system development 
phase. During this phase the product is built using 
the system development lifecycle.  
The final phase is on-going and irregular 
activities. The phase contains a number of practices 
that should be performed during the development of 
the product however; they do not fall under 
individual stages of the software development 
lifecycle. As these do not follow a strict sequence 
they are not included as numbered steps. 
Table 1 outlines the steps included within each 
phase of the roadmap. The planning phase contains 6 
steps, the systems development phase contains 16 
steps and the on-going and event driven phase 
contains 9 steps. 
 
  
 Table 1: Steps in the QMS roadmap 
Planning Phase Systems Development Phase On-going and Irregular Activities Phase 
Appoint a quality manager Gather customer requirements Risk analysis 
Define quality objectives Assign resources Document management 
Establish product scope Analyse system requirements Software configuration management 
Establish SDLC Design the system architecture Quality assurance 
High level planning Software development Validation and verification 
Low level planning Software requirements analysis Software review and audit 
 Software architectural design Problem resolution 
 Detail the software design Change request management 
 Software construction Acquisition 
 Software integration  
 Software qualification testing  
 Software installation  
 System integration  
 System qualification testing  
 Delivery  
 Customer support  
 
3.1 Project Planning Phase 
The first section of the roadmap should be 
performed prior to the development of the medical 
device. During this phase the organisation will 
establish the product scope and the procedures to be 
used during the development of the medical device.  
Step 1: Appoint a quality manager. The first 
step in implementing a QMS is to assign a member 
of the management team responsibility for 
overseeing and reporting on the QMS, and 
promoting the awareness of regulatory and customer 
requirements throughout the organisation.  
Step 2: Define quality objectives and policy. 
The quality objectives and policy outline the 
organisations commitment to quality and guide the 
processes used to ensure product quality. At this 
stage the organisation’s quality manual 
incorporating the scope of the QMS, and details and 
justification for any exclusion and/or non-
application, is established. 
Step 3: Establish the product scope. This step 
involves the definition of the customer requirements 
and an internal analysis of the organisations ability 
to meet these. In addition to this a communications 
interface should be established to ensure effective 
communication between the customer and the 
organisation.  
Step 4: Establish the Software Development 
Lifecycle (SDLC) for the project. During this step 
the organisation should define the software 
development lifecycle that should be used during the 
development of the product. This should include all 
processes necessary for the QMS and the sequence 
and interaction between these processes. 
Step 5: High Level Planning. The next step is to 
define the high level processes necessary for the 
development of the product. For example, 
development of a document management strategy. 
Step 6: Low-level planning. While high-level 
processes define the overall strategy to be employed, 
the low-level processes are focused on particular 
areas or provide more detailed instructions to meet 
the overall strategy.  
3.2 System Development Phase 
After the planning phase has been completed, the 
organisation will begin to develop the medical 
device. These steps follow the order of the software 
development lifecycle and can be implemented in 
the presented order.  
Step 7: Gather Customer requirements. The 
first step of this phase is to determine the customer 
requirements for the project. As part of this stage, 
risk analysis should be performed and documented.  
Step 8: Assign resources. When the customer 
requirements have been defined and understood top 
management should ensure that adequate resources, 
in terms of personnel and infrastructure, are in place 
and documented.    
Step 9: Analyse System requirements. In this 
step, non-functional requirements, potential risks 
and performance expectations are identified. The 
process, and consistency with customer 
requirements, should be documented and 
maintained.  
Step 10: Design the system architecture. If 
external software components are to be used an 
appropriate acquisition strategy should be in place. 
 The system architecture design should be consistent 
with the system requirements and the process used 
should be adequately documented. 
Step 11: Software development. The software 
implementation process to be used during the project 
should be documented and maintained. If any 
deviation from this process is encountered the 
relevant documentation should be updated. 
Step 12: Software Requirements analysis. The 
requirements of the software component of a 
medical device are analysed in the context of the 
complete system and its operating environment. 
Traceability and adequate testing should be ensured. 
Risk control measures should be implemented and 
any modifications to the system requirements should 
be documented.  
Step 13: Software Architectural design. As 
part of the QMS, it is necessary to ensure that the 
architectural design is consistent with the system and 
software requirements. 
Step 14: Detail the software design. A detailed 
software design document should be produced. This 
shall be consistent with the system architecture. The 
process used should be adequately documented. 
Step 15: Software construction. The software 
units defined in the software design document 
should be constructed. Detailed documentation, 
including traceability, should be maintained as 
required by the configuration management strategy.  
Step 16: Software integration. The software 
units should be integrated into the complete software 
system. The integrated system should be tested 
independently from the testing of individual 
components. The results from this testing, as well as 
the strategy for integration and testing should be 
documented and maintained.  
Step 17: Software Qualification Testing. In 
this step the integrated software system is tested. 
User documentation should be updated as necessary. 
A fundamental component of this stage is to ensure 
that a regression test strategy is developed and 
carried out. All processes used and results obtained 
should be documented and maintained. 
Step 18: Software Installation. Documented 
procedures, including verification and acceptance 
criteria, should be established as part of the QMS. 
This documentation should be made available to 
other agents who have been authorised by the 
customer to perform installation activities.  
Step 19: System Integration. The next step is to 
integrate the software with the overall system. Each 
component of the system should be independently 
verified to ensure that they meet the system 
requirements. The results of such verification and 
the process used should be documented. Traceability 
should be ensured.  
Step 20: System Qualification Testing. As part 
of the system qualification testing phase, a QMS 
should ensure that the system tests can be traced 
back to system requirements. The process used 
should be documented and maintained.  
Step 21: Delivery. The QMS requires that the 
organisation should ensure that delivery conditions, 
in accordance with the supply agreement, are met.  
Step 22: Customer Support. The QMS should 
ensure that the organisation monitors the operational 
use and ensure that adequate support is available to 
the customer. The organisation should also collect 
and retain customer satisfaction data relating to both 
the product and the customer service.  
3.3 On-Going and Irregular 
Activities Phase 
During the development process a number of 
activities are performed at regular intervals or when 
specific events occur. The schedule for these 
activities should be defined during the planning 
phase; however, the execution of these activities can 
occur at any time.  
Risk Analysis. At all stages of the product 
development, the organisation should ensure that 
adequate risk management activities are performed. 
The level of risk analysis is dependent upon the class 
of device that is being developed.  
Document management. Throughout the entire 
development process a consistent document 
management process should be in place. Each 
document should be checked before distribution, 
ensuring they are available where needed.  
Software configuration management. During 
the lifetime of the project, configuration items 
should be maintained and accessible at the point of 
use. The QMS should ensure that each configuration 
item is uniquely identified and that a description of 
each item is maintained.  
Quality assurance. The QMS dictates that 
regular assessments should be performed in terms of 
both the processes used during the development of 
the product and the product itself. Through 
processes assessment activities the organisation 
should perform process improvement activities when 
possible. 
The organisation should also periodically assess 
the achievement of the quality objectives and 
monitor the performance of the QMS. When a 
deviation from the quality objective is found, the 
organisation should strive to take action as quickly 
 as possible to ensure that the quality of the product 
is not negatively affected.  
Part of the assessment and improvement 
initiatives should be commitment from all relevant 
departments within the organisation. This will 
ensure assessment activities will not interfere with 
the main functions of the organisational units under 
assessment. The results of the assessment and any 
process improvement activities that will take place 
should be communicated to all stakeholders. 
Validation and Verification. At regular 
intervals the organisation should perform validation 
and verification activities to ensure that the product 
is correct and meets project requirements and quality 
standards. The results of these activities should be 
recorded and any problems identified should be 
entered into a software problem resolution process. 
The results of such activities should be 
communicated to all relevant stakeholders. 
Software review and audit. At regular intervals 
the organisation shall prepare and conduct a 
software review and audit. If a product is found to be 
non-conforming then the organisation should take 
appropriate action either by removing the non-
conformities or by authorising its release under 
concession. If the product is released under 
concession, the organisation should ensure that it 
still meets all regulatory requirements. The nature of 
the non-conformity and the identity of the person(s) 
authorising the concession should be documented. 
Problem Resolution. The organisation should 
ensure that any problem identified is recorded and 
the root cause of the problem is diagnosed. The 
organisation should have procedures in place to alert 
users of the problem pending a fix or a change. A 
solution for the problem should then be found and 
implemented while tracking the status of the issue 
until it is resolved. If no action is taken as a result of 
a problem being identified, the organisation should 
justify and record why no action has been taken. The 
organisation shall maintain records of all customer 
complaints. 
Change request management. A documented 
procedure should be in place to address change 
requests. This procedure should ensure that an audit 
trail is in place enabling traceability. Prior to the 
implementation the organisation should assess the 
impact of the change request on both the existing 
system and other change requests. Additionally the 
risks associated with the change request should be 
analysed. 
Upon implementation of the change request, the 
organisation should perform all necessary 
verification and validation activities. All 
configuration items should be updated if impacted 
by the change.  
Acquisition. In the event the organisation shall 
incorporate external software units in the product, 
the organisation should ensure that an appropriate 
acquisition process is followed. This process should 
encompass a process for supplier tendering and 
selection, acquisition of the product, acceptance 
criteria and testing and a means for managing 
changes and resolving issues with the supplier.  
4. VALIDATION 
Two aspects, order and completeness, of the 
roadmap presented above will be validated. Order 
refers to the placement of the practices in each step. 
It will be necessary to ensure that all practices that 
are depended upon are in place before an 
organisation tries to implement any new practices. 
The completeness of the roadmap refers to its ability 
to cover the requirements of the ISO 13485 standard.  
The order of the implementation steps will be 
validated using the Medi SPICE dependency graphs 
(Flood et al., 2012). The practices in each step will 
be validated to ensure that all dependant practices of 
each step are performed in the same or preceding 
steps. If a practice is found to be performed in the 
same step of the roadmap the organisation will be 
alerted and instructed to perform this practice before 
any dependant ones. 
In order to validate the completeness of the 
roadmap a number of qualified ISO 13485 assessors 
will be asked to review it. A semi-structured 
interview will then be conducted with the assessor. 
5. LIMITATIONS AND FUTURE 
WORK 
The roadmap presented here is based on ISO 13485. 
In the US the FDA produce a similar regulation, 
FDA Regulation 21 CFR 820 (FDA, 2007), for 
organisations wishing to distribute medical devices 
within the US. Although both documents provide 
similar guidance additional practices may be 
required for medical device organisations wishing to 
operate within the US. However, it should be noted 
that the FDA are currently implementing a pilot 
programme to accept a QMS that is compliant with 
ISO 13485. 
The next step of this work will be to perform a 
similar analysis of the FDA Regulation 21 CFR 820. 
 The relevant best practices will be identified and any 
additional requirements identified will be 
incorporated into the existing roadmap to produce a 
roadmap for organisations wishing to distribute 
medical devices in Europe and the US.   
The roadmap presented above allows an 
organisation to create a QMS, assuming they have 
no existing processes in place. In the case of 
software development organisations wishing to enter 
the medical device domain, some existing processes 
may be in place and the roadmap will need to be 
tailored for these organisations. 
In addition to this there are some steps that may 
not need to be performed, depending on the 
circumstances of the organisation or product.  
To address these issues an assessment method 
that can be used to determine the organisations 
existing processes and their specific requirements 
will be developed.  
6. CONCLUSIONS  
This paper presents a software process roadmap for 
the implementation of a QMS for organisations 
operating within the medical device domain. In 
order for medical device products to be sold, they 
must be approved by the relevant regulatory body 
within the region the device is to be sold, such as the 
FDA in the US. The regulations set forth by these 
organisations require that a QMS is in place during 
the development and distribution of medical devices. 
To assist organisations wishing to develop 
medical devices, this paper details a software 
process roadmap for implementing a QMS. This 
roadmap is based on the ISO 13485, an International 
standard detailing the requirements of a QMS for 
organisations in the medical device domain, and the 
base practices defined in the Medi-SPICE PAM. 
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